PTGS2 and neoplasm: In tumor-bearing mice, concurrent blockade of cyclooxygenase-2 (COX-2), which is a key enzyme in inducing suppressive myeloid cells9,10, significantly enhanced the antitumor effects of checkpoint inhibitors.11